Spine using a level-of-evidence grading system. The ratings were compared to previously published ratings of 2 orthopedic journals with similar impact factors.
Recent published studies, editorial content, and practices of major orthopedic journals indicate that levels of evidence in clinical research are receiving increased attention. [1] [2] [3] More than 20 years ago, David Sackett 4 proposed a grading system to categorize more appropriately clinical research studies, based on level of evidence. Sackett has altered his own grading criteria several times over the years, with his latest version from 2001 available on the Oxford Centre for Evidence-Based Medicine Web site. 5 In January 2003, The Journal of Bone and Joint Surgery. American Volume (J Bone Joint Surg Am) editorial board adopted a level-of-evidence rating system that is a modification of Sackett's most recent proposal. 6 Since then, J Bone Joint Surg Am has included a level-of-evidence rating for each of its clinical scientific papers. The American Journal of Sports Medicine (Am J Sports Med) followed suit in January 2005. 7 Both publications categorize each article into 1 of 5 "levels" (i.e., I, II, III, IV, or V) based on its design. J Bone Joint Surg Am also categorizes each study into a "type" (i.e., therapeutic, prognostic, diagnostic, or economic/decision analysis), while Am J Sports Med has contributors select a descriptor for their study design from a list of 11 choices (i.e., metaanalysis, case-control). These rating systems serve to introduce both authors and readers to the notion of level of evidence and stress the importance of using level-of-evidence ratings as a guide in the interpretation of a clinical paper.
Well-designed randomized controlled trials and systematic reviews of such are level I studies, randomized controlled trials with less than 80% follow-up or unclear randomization and prospective cohort studies with control groups are level II, case-control studies and retrospective cohort studies are level III, case series are level IV, and expert opinions are level IV ( Spine, with a similar Journal Impact Factor to Am J Sports Med and J Bone Joint Surg Am, lists neither level of evidence nor study type for clinical scientific articles. Our aim with this project was to evaluate both the types and levels of evidence in Spine for the first half of 2003, which was the same time period as in 2 recent orthopedic level-of-evidence papers, using the hierarchical rating system as provided by J Bone Joint Surg Am in its January 2003 edition. We compared these to the levels of evidence and types of studies found during the same period in J Bone Joint Surg Am and Am J Sports Med. Assessment of Level of Evidence. Two reviewers, each from the same academic institution, participated in the study: one an orthopedic surgeon with a master's degree in public health, and the other a resident in orthopedic surgery. Both reviewers rated all 112 Spine articles and were blinded from each other's ratings. Each reviewer graded the clinical papers based on the modification of Sackett's grading system provided in J Bone Joint Surg Am, January 2003. Reviewers graded articles for the following: (1) the type of study (therapeutic, prognostic, diagnostic, or economic/decision analysis); and (2) the level of evidence (I through IV). When disagreement occurred between reviewers regarding the proper classification of either the type or level of a particular paper, those articles were subsequently discussed in detail until reviewers reached a consensus.
Methods

Eligibility
Once agreement was achieved for Spine ratings, they were analyzed alongside the previously published ratings from Data Analysis. The clinical papers were analyzed in order to determine the frequency of the certain study types (therapeutic, prognostic, diagnostic, or economic/decision analysis) and levels of evidence (I through IV) for Spine individually, and in combination with Am J Sports Med and J Bone Joint Surg Am. Also, the proportion of level I and level II articles was compared to the 2003 Journal Impact Factor for each journal to determine whether a correlation existed between the 2. Finally, the interobserver reliability between reviewers was calculated using kappa values. We used Landis and Koch's 10 method to assess the kappa value. We used equidistant and adjusted weighting to calculate the kappa value. Weighted kappa statistics allow for measuring observer agreement in rank scales, taking into account the agreement by chance while incorporating the magnitude of disagreement into the overall calculation. Figure 1 shows this consistency.
Overall, the majority (119; 53.4%) of the 223 articles from Spine, Am J Sports Med, and J Bone Joint Surg Am were therapeutic, and most reflected level IV evidence (118; 52.9%) (Figures 2, 3 ). There were 37 (16.6%) level I studies, 48 (21.5%) level II studies, and 20 (9.0%) level III studies. Specifically for Spine, 18 (16.1%) of the papers contained level I evidence, 25 (22.3%) level II evidence, 9 (8.0%) level III evidence, and 60 (53.6%) level IV.
For the 3 specified journals, prognostic and diagnostic articles were more likely to have high levels of evidence (level I or II) than therapeutic articles (Tables 2, and 3 ). In fact, 72.3% (86 of 119) of therapeutic articles contained level IV evidence. Economic articles were too uncommon to draw any conclusions about them. The Fisher exact test indicated that the percentage of articles with high levels of evidence was not the same for all article types (P Ͻ 0.001). Consistent with the study by Obremskey et al, 9 we found that most of the articles were therapeutic in type. This reflects a trend in orthopedic literature to publish studies addressing results of specific treatments. Economic studies continued to be infrequent, accounting for 0.5% of all studies. These studies can be especially valu- able because of their potential large-scale impact on decision making in health care systems but are rarely published in orthopedic surgery literature.
A majority of the studies represented level IV evidence. This finding verifies a well-known weakness in the literature: the tendency to publish retrospective studies with a lower level of evidence. The trend was especially evident among therapeutic studies, with the vast majority (81.5%) containing level III or IV evidence. This likely reflects the inherent difficulty in designing and executing a randomized controlled trial, as well as reluctance among clinicians and patients to deviate from their concepts of what the optimum treatment should be.
Studies with a lower level of evidence do have their place in orthopedic research. A level IV study may be the only research design feasible to address a given clinical question regarding an infrequently occurring problem, and such a study can indeed provide valuable information. Also, given patient expectations, medicolegal concerns, and ethical standards, the inclusion of a control group may be difficult or impossible. Features of a welldesigned, well-executed level IV study include a population in which 100% of the patients have the same diagnosis, use of strict inclusion and exclusion criteria, prospective and consecutive patient enrollment, use of a standard treatment protocol, follow-up of patients at specified time intervals, well-defined outcome measures that include clinical parameters, and use of patientderived validated instruments for functional assessment. In addition, the follow-up rate should be Ͼ80%, and the investigators should account for all patients who have been lost to follow-up. Inclusion of these features in a level IV study can help decrease the known and unknown factors that can lead to bias in the design or interpretation of the study. Although a well-designed level IV study can provide valuable information for patient care, investigators should, whenever possible, pursue studies with a higher level of evidence to answer a given clinical question. Several papers that we reviewed could have qualified as cohort studies (level II or III) instead of case series (level IV) if the author(s) had included a control group for comparison. We recommend that authors make every attempt to use a control group in their studies. A control group gives a study the ability to show cause and effect instead of simply revealing trends, improving the confidence with which one can clinically apply the results. The ultimate goal in the evidence-based hierarchy is to produce more level I and II studies, which are more reliably applicable to patient care. We hope that by continuing the study of the percentages of level I and II studies in the literature, investigators will be more likely to tailor their studies to attain this level. We also hope that editors will be more apt to include such studies in their publications.
This study had limitations. The inclusion of only experienced reviewers would likely have yielded a higher level of agreement, but the kappa values in this study are comparable to other studies. Second, some articles were not included (i.e., animal studies, cadaveric studies, case reports, editorials, review articles, and basic science studies) as the level-of-evidence system includes rankings for only clinical studies. Basic Science articles can have excellent study design, data collection, and analysis that provide insight into clinical problems. The quality of basic science articles in these journals is not reflected in this study. Also, few economic studies were encountered in our study. Third, the designated journals published an unequal number of articles during the designated time period. Fourth, this study did not address the quality or utility of the ranked studies. We acknowledge that it is possible to produce a poorly designed, marginally applicable study that ranks higher than a well-executed, clinically important case series. The ranking system we used does not address this situation. Fifth, the Spine article rankings were compared to Am J Sports Med and J Bone Joint Surg Am rankings from the same time period but from a previous study, though this previous study's rankings were in fact the rankings compiled by the current study's senior investigator. As other studies have verified the interobserver reliability of the level-of-evidence ranking system, and since the purpose of this study was to fill in the "gap" left by the omission of Spine from Obremskey's multijournal level-of-evidence study, we did not feel that rerating the Am J Sports Med and J Bone Joint Surg Am papers was necessary. Finally, we are unable to determine from our 6-month data pool if results of this study are generalizable to the population of studies published in these journals.
Conclusions
Spine articles were as likely to contain level I or II evidence as articles in J Bone Joint Surg Am or Am J Sports Med over the same time period. We believe that the level-of-evidence rating system represents an important move in the right direction for evidence-based spine research. Inherent to the discussion of level of evidence is the larger question of evidence-based medicine, of which level of evidence is 1 facet. Discussion abounds on the utility or degree of applicability of evidence-based medicine, especially in regards to surgical patient problems and decision making. 11 Indeed, formulating and executing a clinical trial, from randomization to recruiting willing subjects, poses special challenges in the orthopedic and spine surgery settings. Yet evidence-based medicine is here to stay, with undeniable benefit to practitioners and patients alike. To remain contemporary and assimilate better the literature, it behooves clinicians to be mindful of the level of evidence when reading clinical papers. It equally behooves investigators and editors to be mindful of the level of evidence when creating and choosing clinical studies. The Board of Directors of the American Academy of Orthopedic Surgeons (AAOS) recently voiced this same sentiment when they approved, in February 2005, the use of level-of-evidence ratings for proper classification of orthopedic studies. 12 We believe Spine should consider following the lead of other orthopedic journals by including types and levels of evidence ratings in the abstracts of clinical articles.
Key Points
• Spine publishes clinical studies with levels of evidence comparable to the 2 orthopedic journals, J Bone Joint Surg Am and Am J Sports Med, with similar impact factors.
• The majority of articles in Spine are therapeutic and have level IV evidence. This is consistent with other orthopedic journals.
• The level of evidence in clinical studies is receiving increased attention, and clinical practitioners and researchers should be able to apply its concepts.
